IL115960A0 - Sensory and motor neuron derived factor (smdf) - Google Patents

Sensory and motor neuron derived factor (smdf)

Info

Publication number
IL115960A0
IL115960A0 IL11596095A IL11596095A IL115960A0 IL 115960 A0 IL115960 A0 IL 115960A0 IL 11596095 A IL11596095 A IL 11596095A IL 11596095 A IL11596095 A IL 11596095A IL 115960 A0 IL115960 A0 IL 115960A0
Authority
IL
Israel
Prior art keywords
smdf
sensory
motor neuron
derived factor
neuron derived
Prior art date
Application number
IL11596095A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL115960A0 publication Critical patent/IL115960A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL11596095A 1994-11-14 1995-11-12 Sensory and motor neuron derived factor (smdf) IL115960A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/339,517 US5770567A (en) 1994-11-14 1994-11-14 Sensory and motor neuron derived factor (SMDF)

Publications (1)

Publication Number Publication Date
IL115960A0 true IL115960A0 (en) 1996-01-31

Family

ID=23329369

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11596095A IL115960A0 (en) 1994-11-14 1995-11-12 Sensory and motor neuron derived factor (smdf)

Country Status (7)

Country Link
US (4) US5770567A (fr)
EP (1) EP0792362A2 (fr)
JP (1) JPH10509149A (fr)
CA (1) CA2204379A1 (fr)
IL (1) IL115960A0 (fr)
MX (1) MX9703476A (fr)
WO (1) WO1996015244A2 (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473423B2 (en) 1994-04-29 2009-01-06 Mayo Foundation For Medical Education And Research Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system
ZA986077B (en) 1997-07-09 2000-01-10 Genentech Inc ErbB4 receptor-specific neuregulin related ligands and uses therefor.
US6121415A (en) * 1997-07-09 2000-09-19 Genentech, Inc. ErbB4 receptor-specific neuregolin related ligands and uses therefor
US6994856B1 (en) * 1997-07-24 2006-02-07 Genentech, Inc. ErbB4 receptor-specific neuregulin related ligands and uses therefor
DE59807982D1 (de) 1997-07-30 2003-05-22 Basf Ag Feste textilwaschmittel-formulierung enthaltend glycin-n, n-diessigsäure-derivate
US8236500B2 (en) 1997-10-23 2012-08-07 The United States Of America, As Represented By The Department Of Veterans Affairs Promoter variants of the alpha-7 nicotinic acetylcholine receptor
US6875606B1 (en) 1997-10-23 2005-04-05 The United States Of America As Represented By The Department Of Veterans Affairs Human α-7 nicotinic receptor promoter
AU2003203831B2 (en) * 1998-02-04 2006-08-10 Genentech, Inc. Use of heregulin as an epithelial cell growth factor
AU2581599A (en) * 1998-02-04 1999-08-23 Genentech Inc. Use of heregulin as an epithelial cell growth factor
US20010023241A1 (en) 1998-02-04 2001-09-20 Sliwkowski Mark X. Use of heregulin as a growth factor
US6225456B1 (en) 1998-05-07 2001-05-01 University Technololy Corporation Ras suppressor SUR-5
US6506889B1 (en) 1998-05-19 2003-01-14 University Technology Corporation Ras suppressor SUR-8 and related compositions and methods
US6017886A (en) * 1998-08-05 2000-01-25 Amgen Inc. Use of NDF peptide as growth factor for sensory epithelium
US6080845A (en) * 1998-08-05 2000-06-27 Amgen Inc. Monoclonal antibody against utricular epithelium
AUPP785098A0 (en) * 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
US6441156B1 (en) * 1998-12-30 2002-08-27 The United States Of America As Represented By The Department Of Health And Human Services Calcium channel compositions and methods of use thereof
US7396810B1 (en) * 2000-08-14 2008-07-08 Oregon Health Sciences University Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
US7393823B1 (en) 1999-01-20 2008-07-01 Oregon Health And Science University HER-2 binding antagonists
US7625859B1 (en) * 2000-02-16 2009-12-01 Oregon Health & Science University HER-2 binding antagonists
ES2307505T3 (es) * 1999-04-06 2008-12-01 Genentech, Inc. Utilizacion de ligandos receptores de erbb en el tratamiento de la diabetes.
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
AU7873200A (en) * 1999-10-08 2001-04-23 Uab Research Foundation Smdf and ggf neuregulin splice variant isoforms and uses thereof
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
US20030082534A1 (en) * 1999-11-16 2003-05-01 Peter Lind Novel G protein-coupled receptors
US7538197B2 (en) 2000-02-11 2009-05-26 Proteosys Ag Use of neuregulin-β as an indicator and/or target
BR0111704A (pt) * 2000-06-16 2003-07-08 Basf Ag Detergentes e agentes de limpeza, processo para a preparação dos mesmos, e, usos e detergentes e de agentes de limpeza
US20020119148A1 (en) 2000-09-01 2002-08-29 Gerritsen Mary E. ErbB4 antagonists
US7582425B2 (en) 2001-09-21 2009-09-01 The Regents Of The University Of Michigan Atlastin
US7108975B2 (en) 2001-09-21 2006-09-19 Regents Of The University Of Michigan Atlastin
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
NZ556507A (en) * 2002-06-03 2010-03-26 Genentech Inc Synthetic antibody phage libraries
EP2305710A3 (fr) 2002-06-03 2013-05-29 Genentech, Inc. Bibliothèques de phages et anticorps synthétiques
WO2004065416A2 (fr) * 2003-01-16 2004-08-05 Genentech, Inc. Banques de phages anticorps synthetiques
US20040157770A1 (en) * 2003-02-10 2004-08-12 The United States Of America As Represented By The Department Of Veterans Affairs Method of inhibiting angiogenesis and neuroblastoma growth with alpha and beta isoforms of neu differentiation factor (NDF alpha and NDF beta)
EP1460425A1 (fr) 2003-03-17 2004-09-22 Boehringer Mannheim Gmbh Enzymes déglycosylés pour conjugués
WO2004084839A2 (fr) * 2003-03-24 2004-10-07 Cady Roger K Methode et article pour le traitement de troubles associes a des neurones sensoriels par une application transdermique de toxine botulinique
US20050239088A1 (en) * 2003-05-16 2005-10-27 Shepard H M Intron fusion proteins, and methods of identifying and using same
AU2004261980A1 (en) * 2003-08-01 2005-02-10 Genentech, Inc. Antibody CDR polypeptide sequences with restricted diversity
US7785903B2 (en) * 2004-04-09 2010-08-31 Genentech, Inc. Variable domain library and uses
AU2005245896A1 (en) * 2004-05-14 2005-12-01 Receptor Biologix, Inc. Cell surface receptor isoforms and methods of identifying and using the same
US20060292554A1 (en) * 2004-05-18 2006-12-28 Genentech, Inc. Major coat protein variants for C-terminal and bi-terminal display
DE102004031470A1 (de) * 2004-06-30 2006-01-26 Zf Friedrichshafen Ag Ölversorgungseinrichtung
WO2006042002A2 (fr) * 2004-10-05 2006-04-20 Oregon Health And Science University Compositions et procedes de traitement de maladie
EP1863927A2 (fr) * 2005-03-15 2007-12-12 Ares Trading S.A. Compositions et methodes destinees a traiter et a diagnostiquer des troubles inflammatoires
US20090170769A1 (en) * 2005-05-13 2009-07-02 Pei Jin Cell surface receptor isoforms and methods of identifying and using the same
EP2465870A1 (fr) 2005-11-07 2012-06-20 Genentech, Inc. Polypeptides de liaison dotés de séquences hypvervariables VH/VL diversifiées et consensuelles
US20070237764A1 (en) * 2005-12-02 2007-10-11 Genentech, Inc. Binding polypeptides with restricted diversity sequences
US8957187B2 (en) * 2005-12-02 2015-02-17 Genentech, Inc. Binding polypeptides and uses thereof
US20070213264A1 (en) 2005-12-02 2007-09-13 Mingdong Zhou Neuregulin variants and methods of screening and using thereof
JP5738516B2 (ja) 2005-12-30 2015-06-24 ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド 心機能改善のためのニューレグリンの徐放
WO2007134050A2 (fr) * 2006-05-09 2007-11-22 Genentech, Inc. Polypeptides de liaison à squelettes optimisés
KR101558626B1 (ko) * 2007-08-29 2015-10-08 바스프 에스이 고체 저발포성 침윤제로서의 에스테르화 알킬 알콕실레이트
MX340564B (es) * 2007-11-16 2016-07-14 Mind-Nrg Sa Isoformas de neurregulina solubles activas modificadas post-traduccionalmente.
EP2083067A1 (fr) 2008-01-25 2009-07-29 Basf Aktiengesellschaft Utilisation de complexants organiques et/ou de liaisons contenant des groupes d'acides de carbone polymères dans une composition de produit de lavage ou de nettoyage
TW201031743A (en) 2008-12-18 2010-09-01 Basf Se Surfactant mixture comprising branched short-chain and branched long-chain components
WO2011003904A1 (fr) 2009-07-10 2011-01-13 Basf Se Mélange de tensioactifs contenant des constituants à chaîne courte et à chaîne longue
CN102906325A (zh) 2010-03-25 2013-01-30 巴斯夫欧洲公司 电化学纺织品洗涤方法
US20110237484A1 (en) * 2010-03-25 2011-09-29 Basf Se Electrochemical textile-washing process
EP2663625B1 (fr) 2011-01-13 2018-06-27 Basf Se Utilisation de thioéthers éventuellement oxydés d'alcoxylates d'alcools dans des détergents et produits de nettoyage
MX2013007897A (es) 2011-01-13 2013-09-13 Basf Se Uso de tioeteres opcionalmente oxidados de polialquilenglicoles en los detergentes y agentes de limpieza.
US8951955B2 (en) 2011-01-13 2015-02-10 Basf Se Use of optionally oxidized thioethers of alcohol alkoxylates in washing and cleaning compositions
US8987183B2 (en) 2011-01-13 2015-03-24 Basf Se Use of optionally oxidized thioethers of polyalkylene oxides in washing and cleaning compositions
WO2013053076A1 (fr) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions et procédés pour le traitement de l'insuffisance cardiaque
WO2015000969A2 (fr) 2013-07-03 2015-01-08 Basf Se Utilisation d'une composition polymère géliforme, obtenue par polymérisation d'un monomère contenant des groupes acides en présence d'un composé polyéther dans des formulations pour le lavage de vaisselle en machine
JP6686361B2 (ja) * 2014-11-26 2020-04-22 東ソー株式会社 細胞回収のための標本作製方法
CN108779212A (zh) 2016-03-16 2018-11-09 巴斯夫欧洲公司 洗涤和清洁活性聚合物膜，其制备方法及其用途
BR112019011724A2 (pt) 2016-12-16 2019-10-22 Basf Se película multicamadas, processo para produzir uma película multicamadas, uso de uma película multicamadas, bainha ou revestimento, e, composição de lavagem ou limpeza.
EP3555153B1 (fr) 2016-12-16 2020-12-09 Basf Se Feuilles multicouches, leur procédé de production et d'utilisation
EP3679118A1 (fr) 2017-09-06 2020-07-15 Basf Se Films polymères actifs de lavage et de nettoyage, leur procédé de production et leur utilisation
EP3820981A1 (fr) 2018-07-11 2021-05-19 Basf Se Procédé de production de polymères stables contenant du vinylimidazole
WO2020035567A1 (fr) 2018-08-16 2020-02-20 Basf Se Films polymères hydrosolubles d'homopolymères ou de copolymères d'oxyde d'éthylène, procédé de calandrage pour leur production et leur utilisation
WO2020249706A1 (fr) 2019-06-14 2020-12-17 Basf Se Dispersions aqueuses de polymères convenant comme opacifiants dans des formulations liquides
WO2021191175A1 (fr) 2020-03-24 2021-09-30 Basf Se Formulation d'un détergent sous la forme d'un corps tridimensionnel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968603A (en) * 1986-12-31 1990-11-06 The Regents Of The University Of California Determination of status in neoplastic disease
EP0597845A1 (fr) * 1990-05-25 1994-05-25 Georgetown University FACTEUR DE CROISSANCE INHIBANT LA CROISSANCE DE CELLULES SUREXPRIMANT L'ONCOGENE HUMAIN erbB-2
DE69229597D1 (de) * 1991-01-14 1999-08-19 Univ Georgetown Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert
GB9107566D0 (en) * 1991-04-10 1991-05-29 Ludwig Inst Cancer Res Glial mitogenic factors,their preparation and use
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
AU676476B2 (en) * 1992-04-29 1997-03-13 Georgetown University Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbB-2-receptor
GB9217316D0 (en) * 1992-08-14 1992-09-30 Ludwig Inst Cancer Res Schwann cell mitogenic factor,its preparation and use

Also Published As

Publication number Publication date
US5667780A (en) 1997-09-16
WO1996015244A2 (fr) 1996-05-23
JPH10509149A (ja) 1998-09-08
US5763213A (en) 1998-06-09
US5770567A (en) 1998-06-23
WO1996015244A3 (fr) 1996-08-08
CA2204379A1 (fr) 1996-05-23
MX9703476A (es) 1997-07-31
US5756456A (en) 1998-05-26
EP0792362A2 (fr) 1997-09-03

Similar Documents

Publication Publication Date Title
IL115960A0 (en) Sensory and motor neuron derived factor (smdf)
IL109268A0 (en) Pattern recognition method and system
GB2288257B (en) Improved nutritional micromcomputer and method
GB2287559B (en) Parallel processor change-apparatus and method
SG32522A1 (en) Surface treatment method and system
GB2286304B (en) Ladder filter and method
IL122428A0 (en) Minizymes and minribozymes and uses thereof
ZA963123B (en) Air filtration arrangement and method.
GB9407939D0 (en) Fingerprint id system and method
AU3673295A (en) Posture change system and posture change method
ZA959118B (en) Al-1 neutrotrophic factor
GB2296257B (en) Sliding member and manufacturing method thereof
GB2288273B (en) Analysis systems and processes
EP0689153A3 (fr) Reconnaissance de caractères
AU1943495A (en) Neuron promoter and uses
AU1733795A (en) Improved facial mask and method
EP0698857A3 (fr) Reconnaissance de formes
EP0662748A3 (fr) Régulateur de tension et méthode pour celui-ci.
EP0759198A4 (fr) Filtre median efficace et methode associee
EP0836617A4 (fr) Parevines et tachytegrines
EP0753802A4 (fr) Systeme et methode de regulation
EP0759036A4 (fr) Molecules immuno-interactives i
GB2310522B (en) Fingerprint ID system and method
GB9523718D0 (en) Filter and filter element
GB2303649B (en) Spacing unit and method